Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2024. Module: SNOMED CT Netherlands NRC maintained module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 14617181000146113 | Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | SNOMED CT Netherlands NRC maintained module (core metadata concept) |
| 14617191000146110 | Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT Netherlands NRC maintained module (core metadata concept) |
| 14617171000146111 | percentage celkernen positief voor p16 antigeen in primair maligne neoplasma volgens immunohistochemie | nl | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT Netherlands NRC maintained module (core metadata concept) |
| 14617201000146112 | percentage celkernen positief voor p16 antigeen in primair maligne neoplasma volgens immunohistochemie (waarneembare entiteit) | nl | Fully specified name | Active | Entire term case sensitive (core metadata concept) | SNOMED CT Netherlands NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | Is a | Observation using immunohistochemistry (observable entity) | true | Inferred relationship | Some | ||
| Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | Is a | Neoplasm observable | true | Inferred relationship | Some | ||
| Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | Inheres in | Malignant neoplasm (morphologic abnormality) | false | Inferred relationship | Some | 6 | |
| Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | Property (attribute) | Number fraction (property) (qualifier value) | false | Inferred relationship | Some | 3 | |
| Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | Scale type (attribute) | Quantitative | false | Inferred relationship | Some | 4 | |
| Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | Characterizes (attribute) | Malignant proliferation of primary neoplasm (qualifier value) | false | Inferred relationship | Some | 7 | |
| Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | Relative to (attribute) | Population of all malignant neoplasm cells in portion of tissue (body structure) | false | Inferred relationship | Some | 8 | |
| Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | Technique | Immunohistochemistry | false | Inferred relationship | Some | 2 | |
| Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | Component | Population of all malignant neoplasm cell nuclei positive for antigen p16 in portion of tissue (body structure) | true | Inferred relationship | Some | 1 | |
| Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | Time aspect (attribute) | Single point in time | false | Inferred relationship | Some | 5 | |
| Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | Inheres in | Malignant neoplasm (morphologic abnormality) | true | Inferred relationship | Some | 1 | |
| Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | Property (attribute) | Number fraction (property) (qualifier value) | true | Inferred relationship | Some | 1 | |
| Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | Scale type (attribute) | Quantitative | true | Inferred relationship | Some | 1 | |
| Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | Characterizes (attribute) | Malignant proliferation of primary neoplasm (qualifier value) | true | Inferred relationship | Some | 1 | |
| Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | Relative to (attribute) | Population of all malignant neoplasm cells in portion of tissue (body structure) | true | Inferred relationship | Some | 1 | |
| Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | Technique | Immunohistochemistry | true | Inferred relationship | Some | 1 | |
| Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) | Time aspect (attribute) | Single point in time | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR